Chronic Polyneuropathy
Chronic inflammatory demyelinating polyneuropathy (CIDP) may be a nervous disorder -- a condition that targets your body’s nerves. Symptoms aren’t an equivalent for everybody, but you'll be tired and have areas of numbness and pain. It can slow your reflexes and make your arms and legs feel weak. You have to possess symptoms for a minimum of 8 weeks for CIDP to be considered the cause. Most people need treatment. And the sooner you begin it, the better the chance of a complete recovery. Sometimes symptoms get away for an extended time but come later. Anyone can get CIDP, but it’s commonest in older adults, and more in men than women. As many as 40,000 people in the U.S. may have the condition, but it’s hard to know how many people have it. CIDP isn’t easy to diagnose. What causes it? Experts aren’t sure why people get the disorder. What they are doing know is that it’s caused by
inflammation of nerves and nerve roots. The swelling can destroy the protective covering around nerves, referred to as myelin. That can hurt nerve fibers and slow the nerves’ ability to send signals. This is what causes the weakness, pain, fatigue, and numbness. How is it diagnosed? There’s no test to diagnosis CIDP. Instead, your doctor will ask you questions on your symptoms, like once they started and the way they feel. He’ll do a radical physical examination and should also recommend tests to urge a far better idea of what’s happening together with your nerves, and to rule out other possible causes. In some cases, doctors can’t be completely sure it’s CIDP, but they'll begin treatment. If the symptoms gets improve, then that’s strong evidence it’s CIDP.
High Impact List of Articles
-
Alvimopan and enhanced recovery pathways in colorectal surgery
Benjamin Crawshaw, Deborah S Keller & Conor P Delaney
Review: Clinical Trail Outcomes: Clinical Investigation
-
Alvimopan and enhanced recovery pathways in colorectal surgery
Benjamin Crawshaw, Deborah S Keller & Conor P Delaney
Review: Clinical Trail Outcomes: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 3
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 3
Acknowledgements: Clinical Investigation
-
Reassessment of the dysplastic nevus concept in the 21st century:a proposal for a two-tiered system of classification
Hebah Aboul-Fotouh, Lauren A Baker, Michelle Lucero Jackson ,Clay J Cockerell
Editorial: Clinical Investigation
-
Reassessment of the dysplastic nevus concept in the 21st century:a proposal for a two-tiered system of classification
Hebah Aboul-Fotouh, Lauren A Baker, Michelle Lucero Jackson ,Clay J Cockerell
Editorial: Clinical Investigation
-
Telavancin in the treatment of nosocomial pneumonia: review of the clinical evidence
Antoni Torres
Review: Clinical Trail Outcomes: Clinical Investigation
-
Telavancin in the treatment of nosocomial pneumonia: review of the clinical evidence
Antoni Torres
Review: Clinical Trail Outcomes: Clinical Investigation
-
Gender differences and clinical trial design
Sabine Oertelt-Prigione
Editorial: Clinical Investigation
-
Gender differences and clinical trial design
Sabine Oertelt-Prigione
Editorial: Clinical Investigation
Relevant Topics in Clinical